Clinical Trials › NCT06136728
RecruitingPhase 4
Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
Sponsored by MGH Institute of Health Professions
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 48
Target enrollment
1
U.S. states
Jun 2024
Start date
Dec 2026
Expected completion
Interventions / Treatments
Dalfampridine 10 MG [Ampyra]Physical therapyDalfampridine plus physical therapy
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Massachusetts1 site
Boston
MS centers in Massachusetts
Compare treatment centers near a trial site by center type, providers and trials.
View Massachusetts centersMore Phase 4 trials
Browse all Phase 4 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.